Pulse Biosciences, Inc.
PLSE
Rankning i aktier
#4185
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aktiekurs
$52.97
Marknadsvärde
$3.78B
Förändring (1 dag)
3.23%
Förändring (1 år)
207.04%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Aktiekurshistorik för Pulse Biosciences, Inc. (PLSE)
Högsta slutkurs: $49.41 den 2026-10-01
Lägsta slutkurs: $4.20 den 2016-05-01
Lägsta slutkurs: $4.20 den 2016-05-01
Aktiekurshistorik för Pulse Biosciences, Inc. från 2016 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 91.56% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $441.33 | -16.26% |
US
|
|
| $197.82 | -45.30% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $198.36 | 34.13% |
US
|
|
| $70.09 | -8.42% |
CH
|
